Sol-Gel Technologies Ltd.
SLGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001684693
In the last 90 days, Sol-Gel Technologies Ltd. insiders filed 8 open-market purchases and 0 sales; 24 institutions reported holding it in 13F filings for Q2 2026, worth $98.1M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Sol-Gel Technologies Ltd. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −1 vs. Q4 2023
- Shares held
- 7.71M
- −252.4K (−3.2%) vs. Q4 2023
- Total value
- $7.56M
- −$1.60M (−17.5%) vs. Q4 2023
- New holders
- 1
- 7 more added
- Sold out
- 2
- 4 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 24 | $98.1M |
| Q1 2026 | 21 | $100.0M |
| Q4 2025 | 14 | $30.2M |
| Q3 2025 | 10 | $16.3M |
| Q2 2025 | 11 | $4.87M |
| Q1 2025 | 21 | $2.76M |
| Q4 2024 | 17 | $4.86M |
| Q3 2024 | 20 | $3.67M |
| Q2 2024 | 20 | $6.56M |
| Q1 2024 | 20 | $7.56M |
| Q4 2023 | 21 | $9.16M |
| Q3 2023 | 18 | $13.1M |
| Q2 2023 | 17 | $23.6M |
| Q1 2023 | 15 | $31.3M |
| Q4 2022 | 14 | $26.0M |
| Q3 2022 | 13 | $29.5M |
| Q2 2022 | 17 | $23.7M |
| Q1 2022 | 17 | $42.9M |
| Q4 2021 | 18 | $43.3M |
| Q3 2021 | 18 | $58.7M |
| Q2 2021 | 16 | $72.6M |
| Q1 2021 | 20 | $71.3M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Sol-Gel Technologies Ltd.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Phoenix Holdings Ltd. | 2,574,922 | $2.52M | 0.03% | 00.0% | Unchanged |
| Armistice Capital, LLC | 2,078,000 | $2.04M | 0.05% | −57,000−2.7% | Reduced |
| Migdal Insurance & Financial Holdings Ltd. | 1,227,548 | $1.20M | 0.02% | 00.0% | Unchanged |
| Harel Insurance Investments & Financial Services Ltd. | 920,333 | $902.0K | 0.02% | 00.0% | Unchanged |
| Kingdon Capital Management, L.L.C. | 481,749 | $472.2K | 0.06% | −193,174−28.6% | Reduced |
| Yelin Lapidot Holdings Management Ltd. | 229,178 | $224.6K | 0.05% | 00.0% | Unchanged |
| Raymond James Financial Services Advisors, Inc. | 49,130 | $48.2K | 0.00% | +6,028+14.0% | Added |
| Morgan Stanley | 38,584 | $37.8K | 0.00% | +9,649+33.3% | Added |
| Raymond James & Associates | 30,977 | $30.4K | 0.00% | +62+0.2% | Added |
| Millennium Management LLC | 20,400 | $20.6K | 0.00% | +7,763+61.4% | Added |
| BNP Paribas Arbitrage, SA | 15,500 | $15.2K | 0.00% | +4,800+44.9% | Added |
| Geode Capital Management, LLC | 13,406 | $13.5K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 11,197 | $11.3K | 0.00% | −6,062−35.1% | Reduced |
| Tower Research Capital LLC (TRC) | 7,371 | $7.22K | 0.00% | +2,588+54.1% | Added |
| Steward Partners Investment Advisory, LLC | 4,160 | $4.08K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,405 | $3.34K | 0.00% | −7,210−67.9% | Reduced |
| BlackRock Inc. | 3,089 | $3.03K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2,411 | $2.36K | 0.00% | +795+49.2% | Added |
| Wells Fargo & Company | 500 | $490 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 526 | $0 | 0.00% | +526 | New |
| Invesco Ltd. | 0 | $0 | 0.00% | −10,660−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,471−100.0% | Sold out |